Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885252913> ?p ?o ?g. }
- W2885252913 endingPage "32399" @default.
- W2885252913 startingPage "32383" @default.
- W2885252913 abstract "// Eva González-Barca 1 , Mónica Coronado 2 , Alejandro Martín 3 , Carlos Montalbán 4 , Santiago Montes-Moreno 5 , Carlos Panizo 6 , Guillermo Rodríguez 7 , Juan Manuel Sancho 8 , Andrés López-Hernández 9 and on behalf of the Spanish Lymphoma Group (GELTAMO) 1 Department of Hematology, Institut Català d’ Oncologia and IDIBELL, L’ Hospitalet de Llobregat, Barcelona, Spain 2 Department of Nuclear Medicine, Hospital Universitario La Paz, Madrid, Spain 3 Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain 4 Department of Hematology, MD Anderson Cancer Center, Madrid, Spain 5 Department of Pathology and Translational Hematopathology Lab, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain 6 Department of Hematology, Clínica Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain 7 Department of Hematology, Hospital Universitario Virgen de la Macarena, Sevilla, Spain 8 Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain 9 Department of Hematology, Hospital Universitario Vall d’Hebron, Barcelona, Spain Correspondence to: Eva González-Barca, email: e.gonzalez@iconcologia.net Keywords: guidelines; DLBCL; risk assessment; treatment; DLBCL entities Received: March 21, 2018 Accepted: July 23, 2018 Published: August 17, 2018 ABSTRACT Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 30% of non-Hodgkin lymphoma (NHL) cases in adult series. DLBCL is characterized by marked clinical and biological heterogeneity, encompassing up to 16 distinct clinicopathological entities. While current treatments are effective in 60% to 70% of patients, those who are resistant to treatment continue to die from this disease. An expert panel performed a systematic review of all data on the diagnosis, prognosis, and treatment of DLBCL published in PubMed, EMBASE and MEDLINE up to December 2017. Recommendations were classified in accordance with the Grading of Recommendations Assessment Development and Evaluation (GRADE) framework, and the proposed recommendations incorporated into practical algorithms. Initial discussions between experts began in March 2016, and a final consensus was reached in November 2017. The final document was reviewed by all authors in February 2018 and by the Scientific Committee of the Spanish Lymphoma Group GELTAMO." @default.
- W2885252913 created "2018-08-22" @default.
- W2885252913 creator A5011313306 @default.
- W2885252913 creator A5012630795 @default.
- W2885252913 creator A5015493927 @default.
- W2885252913 creator A5018422609 @default.
- W2885252913 creator A5038940783 @default.
- W2885252913 creator A5041947496 @default.
- W2885252913 creator A5048566051 @default.
- W2885252913 creator A5074244429 @default.
- W2885252913 creator A5087321681 @default.
- W2885252913 date "2018-08-17" @default.
- W2885252913 modified "2023-10-06" @default.
- W2885252913 title "Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma" @default.
- W2885252913 cites W1094999820 @default.
- W2885252913 cites W131348520 @default.
- W2885252913 cites W1544269146 @default.
- W2885252913 cites W1572459595 @default.
- W2885252913 cites W1594481026 @default.
- W2885252913 cites W1595368274 @default.
- W2885252913 cites W1954043953 @default.
- W2885252913 cites W1968860073 @default.
- W2885252913 cites W1971277013 @default.
- W2885252913 cites W1971815003 @default.
- W2885252913 cites W1976388915 @default.
- W2885252913 cites W1982834279 @default.
- W2885252913 cites W1997353354 @default.
- W2885252913 cites W1999897515 @default.
- W2885252913 cites W2001196047 @default.
- W2885252913 cites W2009002059 @default.
- W2885252913 cites W2015017263 @default.
- W2885252913 cites W2024972915 @default.
- W2885252913 cites W2026374501 @default.
- W2885252913 cites W2028311823 @default.
- W2885252913 cites W2028850684 @default.
- W2885252913 cites W2029421916 @default.
- W2885252913 cites W2033242559 @default.
- W2885252913 cites W2034881106 @default.
- W2885252913 cites W2043622833 @default.
- W2885252913 cites W2044287233 @default.
- W2885252913 cites W2056555760 @default.
- W2885252913 cites W2056641238 @default.
- W2885252913 cites W2056672315 @default.
- W2885252913 cites W2058015212 @default.
- W2885252913 cites W2060413939 @default.
- W2885252913 cites W2060527830 @default.
- W2885252913 cites W2060844658 @default.
- W2885252913 cites W2063691874 @default.
- W2885252913 cites W2064223130 @default.
- W2885252913 cites W2067709915 @default.
- W2885252913 cites W2072351874 @default.
- W2885252913 cites W2075864830 @default.
- W2885252913 cites W2077320602 @default.
- W2885252913 cites W2084211448 @default.
- W2885252913 cites W2085022705 @default.
- W2885252913 cites W2085459287 @default.
- W2885252913 cites W2085561179 @default.
- W2885252913 cites W2091838920 @default.
- W2885252913 cites W2095891194 @default.
- W2885252913 cites W2096764404 @default.
- W2885252913 cites W2097145287 @default.
- W2885252913 cites W2097561270 @default.
- W2885252913 cites W2106810047 @default.
- W2885252913 cites W2106928992 @default.
- W2885252913 cites W2107071884 @default.
- W2885252913 cites W2109806588 @default.
- W2885252913 cites W2110372244 @default.
- W2885252913 cites W2111716055 @default.
- W2885252913 cites W2111827890 @default.
- W2885252913 cites W2115637639 @default.
- W2885252913 cites W2117460825 @default.
- W2885252913 cites W2119091791 @default.
- W2885252913 cites W2119147717 @default.
- W2885252913 cites W2120415962 @default.
- W2885252913 cites W2121824293 @default.
- W2885252913 cites W2122863546 @default.
- W2885252913 cites W2125577669 @default.
- W2885252913 cites W2126226253 @default.
- W2885252913 cites W2126779872 @default.
- W2885252913 cites W2127682234 @default.
- W2885252913 cites W2128732540 @default.
- W2885252913 cites W2130997237 @default.
- W2885252913 cites W2131424155 @default.
- W2885252913 cites W2131900456 @default.
- W2885252913 cites W2133345449 @default.
- W2885252913 cites W2133977062 @default.
- W2885252913 cites W2134138207 @default.
- W2885252913 cites W2136268782 @default.
- W2885252913 cites W2137348614 @default.
- W2885252913 cites W2139450265 @default.
- W2885252913 cites W2140362403 @default.
- W2885252913 cites W2142814377 @default.
- W2885252913 cites W2144329058 @default.
- W2885252913 cites W2145453495 @default.
- W2885252913 cites W2147246240 @default.
- W2885252913 cites W2150587745 @default.
- W2885252913 cites W2153549003 @default.
- W2885252913 cites W2155911595 @default.